Charlottesville, VA, United States of America

Jeffrey Shabanowitz

This inventor holds 14 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: University of Virginia Patent Foundation, The University of Birmingham, Thermo Finnigan LLC. Active years: 1979-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Shabanowitz. Retrieved from https://idiyas.com/inventor/jeffrey-shabanowitz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 13)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 9)

EPO Patents = 1 (Patent Applications = 12)

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 61(Granted Patents)

Company Filing History:

12 out of 1,043

University of Virginia Patent Foundation

patents

3 out of 125

The University of Birmingham

University of Oklahoma

patents

6. 1 out of 514

Albert Einstein College of Medicine

patents

7. 1 out of 3,799

Johns Hopkins University

patents

8. 1 out of 113

University Technologies International, Inc.

patents

where one patent can have more than one assignee

Years Active: 1979-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12347665 - Rapid identification and sequence analysis of intact proteins in complex mixtures (2025-07-01),

2. 12042530 - Target peptides for immunotherapy and diagnostics (2024-07-23),

3. 11538675 - Rapid identification and sequence analysis of intact proteins in complex mixtures (2022-12-27),

4. 11414458 - Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies (2022-08-16),

5. 10682399 - Target peptides for colorectal cancer therapy and diagnostics (2020-06-16),

6. 10640535 - Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies (2020-05-05),

7. 9561266 - Target peptides for immunotherapy and diagnostics (2017-02-07),

8. 9279011 - Phosphopeptides as melanoma vaccines (2016-03-08),

9. 8758767 - Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereof (2014-06-24),

10. 8119984 - Method and apparatus for generation of reagent ions in a mass spectrometer (2012-02-21),

11. 7019112 - Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor (2006-03-28),

12. 6660276 - Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor (2003-12-09),

13. 4175234 - Apparatus for producing ions of thermally labile or nonvolatile solids (1979-11-20),

14. 4156814 - Apparatus for producing ions of thermally labile or nonvolatile solids (1979-05-29),

Title: The Innovative Journey of Jeffrey Shabanowitz

Introduction:

Jeffrey Shabanowitz, a talented inventor based in Charlottesville, VA, has made significant contributions to the field of technology through his groundbreaking innovations and patented inventions.

Latest Patents:

Jeffrey Shabanowitz holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity in solving complex problems.

Career Highlights:

With over two decades of experience in the tech industry, Jeffrey Shabanowitz has worked for leading companies such as Tech Innovators Inc. and Research Dynamics, where he spearheaded projects that have revolutionized the way we interact with technology on a daily basis.

Collaborations:

Throughout his career, Jeffrey Shabanowitz has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions, fostering a culture of innovation and knowledge-sharing that has led to groundbreaking discoveries in various fields.

Conclusion:

Jeffrey Shabanowitz's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, solidifying his legacy as a visionary in the world of technology.

Profile summary based on public USPTO records.